SCHEMBL33889

SCHEMBL33889

C=C(C)C(=O)CC[N+](C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.46
CHRM5 P08912 4/20 0.39
CHRM1 P11229 4/20 0.39
CHRM3 P20309 4/20 0.39
CHRM2 P08172 3/20 0.39
CHRM4 P08173 3/20 0.39
CYP2C19 P33261 3/20 0.39
HTR1A P08908 2/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNA7 P36544 2/20 0.39
CHRNA4 P43681 2/20 0.39
ADRA2A P08913 1/20 0.39
ADRA1A P35348 1/20 0.39
PGR P06401 1/20 0.39
TBXA2R P21731 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7628216 0.98 ACHE (0.44) ACHECHRM5CHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL525772 0.98 ACHE (0.44) ACHECHRM5CHRM1CHRM3CHRM2
Iodide SCHEMBL8612631 0.98 ACHE (0.44) ACHECHRM5CHRM1CHRM3CHRM2
Sulfuric Acid SCHEMBL774507 0.91 ACHE (0.40) ACHECHRM5CHRM1CHRM3CHRM2
SCHEMBL21457873 0.86 ACHE (0.60) ACHECHRM5CHRM1CHRM3CHRM2
SCHEMBL11528594 0.84 ACHE (0.35) ACHECHRM5CHRM1CHRM3CHRM2
SCHEMBL4091792 0.84 POLB (0.39) ACHECHRM5CHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL15419542 0.84 ACHE (0.58) ACHECHRM5CHRM1CHRM3ADRA2A
SCHEMBL26489449 0.84 ACHE (0.52) ACHECHRM5CHRM1CHRM3CHRM2
Hydrochloric Acid SCHEMBL8166002 0.84 ACHE (0.41) ACHECHRM5CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1929 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281265-A1 TREATED SUBSTRATES AND METHODS OF PRODUCING THE SAME Solenis Technologies Cayman, L.P. (CH) 2023-11-29 EP claimed
US-11771639-B2 Aqueous composition comprising a cationic cellulosic polymer, an anionic surfactant comprising at least one cationic counterion, a fatty phase and a pigment L'OREAL (FR) 2023-10-03 US claimed
US-20230037007-A1 AQUEOUS COMPOSITION COMPRISING A CATIONIC CELLULOSIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT L'OREAL (FR) 2023-02-02 US claimed
CN-114786780-A Aqueous composition comprising a cationic cellulose polymer, an anionic surfactant comprising at least one cationic counterion, a fatty phase and a pigment 莱雅公司 2022-07-22 CN claimed
US-20220228320-A1 TREATED SUBSTRATES AND METHODS OF PRODUCING THE SAME SOLENIS TECHNOLOGIES, L.P. (US) 2022-07-21 US claimed
US-20220178797-A1 POLYCATIONIC QUATERNARY AMMONIUM POLYMER COATINGS FOR IMMOBILIZING BIOLOGICAL SAMPLES TRIPATH IMAGING, INC. 2022-06-09 US claimed
WO-2021122383-A1 AQUEOUS COMPOSITION COMPRISING A CATIONIC CELLULOSIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT L'OREAL (FR) 2021-06-24 WO claimed
WO-2019002150-A1 COSMETIC COMPOSITION COMPRISING A MIXTURE OF PARTICULAR CARBOXYLIC SURFACTANTS, NON-IONIC AND AMPHOTERIC SURFACTANTS, AND CATIONIC POLYMERS, COSMETIC TREATMENT PROCESS AND USE L'OREAL (FR) 2019-01-03 WO claimed
WO-2019002149-A1 Cosmetic composition comprising organosilanes, cationic polymers, liquid fatty substances, particular anionic surfactants, and non-ionic and amphoteric surfactants, cosmetic treatment process and use L'OREAL (FR) 2019-01-03 WO claimed
EP-2343042-B1 Cosmetic composition containing at least one organic silicon compound, at least one anionic surface-active agent and at least one cationic polymer L'ORÉAL (FR) 2017-10-18 EP claimed
EP-0889940-A1 ELECTROSPRAYABLE RELEASE COATING MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-01-13 EP claimed
US-5858545-A COMPRISING AN UNSATURATED MONOMER, A POLYSILOXANE HAVING UNSATURATED END GROUPS AND ONE OR MORE NONVOLATILE CONDUCTIVITY ENHANCER SOLUBLE IN THE MONOMER AND NOT INTERFERING WITH THE COPOLYMERIZATION MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-01-12 US claimed
WO-1997035941-A1 ELECTROSPRAYABLE RELEASE COATING MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-10-02 WO claimed
EP-0278540-B1 COMPOSITION AND METHOD FOR FLUID LOSS CONTROL IN ACID FRACTURING OF EARTHEN FORMATIONS COMPAGNIE DES SERVICES DOWELL SCHLUMBERGER (FR) 1992-08-05 EP claimed
EP-0213317-B1 BASE-CATALYZED, LOW TEMPERATURE SELF-CROSSLINKING POLYMERS National Starch and Chemical Investment Holding Corporation (US) 1991-12-04 EP claimed
US-4857303-A Dentifrice gel L'OREAL (FR) 1989-08-15 US claimed
US-4839166-A COPOLYMER OF CELLULOSE OR DERIVATIVE GRAFTED WITH QUATERNARY AMMONIUM SALT AND CARBOXYLIC ANIONIC POLYMER L'OREAL (FR) 1989-06-13 US claimed
US-4820308-A AMINE-SUBSTITUTED POLYSILOXANES, QUATERNIZED CELLULOSE ETHERS, CYCLOPOLYMERS L'OREAL (FR) 1989-04-11 US claimed
US-4710314-A BLEND OF SOAP, CATION OLYMERS AND SURFACTANTS L'OREAL (FR) 1987-12-01 US claimed
EP-0107226-B1 WATER-IN-OIL EMULSIONS OF WATER-SOLUBLE CATIONIC POLYMERS AND A PROCESS FOR PREPARING SUCH EMULSIONS THE DOW CHEMICAL COMPANY (US) 1986-09-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230037007-A1 AQUEOUS COMPOSITION COMPRISING A CATIONIC CELLULOSIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT KRT18, CUTA, DSC1 ACHE 2745/4885CHRM5 1257/4885CHRM1 2126/4885
US-11771639-B2 Aqueous composition comprising a cationic cellulosic polymer, an anionic surfactant comprising at least one cationic counterion, a fatty phase and a pigment KRT18, CUTA, DSC1 ACHE 2850/4885CHRM5 944/4885CHRM1 1835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.